TRANSMEMBRANE PROSTATIC ACID PHOSPHATASE IS A MARKER, DRIVER AND THERAPEUTIC TARGET FOR LETHAL PROSTATE CANCER.

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators